Cordant, Inc. Bristol Myers Squibb CO Transaction History

Cordant, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 17, 2022	SELL	$72.62 - $79.98 $18,227 - $20,074	-251 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $15,431 - $18,503	251 New	251 $18,000
Q4 2021 Jan 25, 2022	SELL	$53.63 - $62.52 $1,287 - $1,500	-24 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $8,934 - $10,465	-151 Reduced 86.29%	24 $1,000
Q2 2021 Jul 27, 2021	BUY	$61.91 - $67.42 $10,834 - $11,798	175 New	175 $12,000
Q1 2020 Nov 18, 2020	SELL	$46.4 - $67.43 $10,115 - $14,699	-218 Closed	0 $0
Q4 2019 Nov 18, 2020	BUY	$49.21 - $64.19 $10,727 - $13,993	218 New	218 $14,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cordant, Inc., based on Form 13F filings with the SEC.

Stay updated on Cordant, Inc. with notifications on news.